Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endarterectomy, Carotid | 11 | 2023 | 564 | 4.100 |
Why?
|
Peripheral Arterial Disease | 21 | 2024 | 1306 | 3.470 |
Why?
|
Carotid Stenosis | 9 | 2024 | 878 | 2.890 |
Why?
|
Arteriovenous Shunt, Surgical | 5 | 2024 | 294 | 2.860 |
Why?
|
Endovascular Procedures | 19 | 2024 | 2165 | 2.030 |
Why?
|
Graft Occlusion, Vascular | 5 | 2024 | 560 | 1.850 |
Why?
|
Stents | 13 | 2024 | 3314 | 1.730 |
Why?
|
Blood Vessel Prosthesis Implantation | 12 | 2024 | 1446 | 1.550 |
Why?
|
Forearm | 2 | 2024 | 429 | 1.470 |
Why?
|
Aortic Aneurysm, Abdominal | 15 | 2024 | 1223 | 1.450 |
Why?
|
Ontario | 22 | 2021 | 404 | 1.440 |
Why?
|
Vascular Surgical Procedures | 9 | 2024 | 1475 | 1.360 |
Why?
|
Renal Dialysis | 4 | 2024 | 1801 | 1.120 |
Why?
|
Databases, Factual | 13 | 2024 | 8035 | 1.100 |
Why?
|
Vascular Patency | 4 | 2023 | 901 | 1.070 |
Why?
|
Angioplasty | 3 | 2017 | 361 | 1.020 |
Why?
|
Carotid Arteries | 3 | 2023 | 951 | 0.980 |
Why?
|
Polytetrafluoroethylene | 1 | 2023 | 245 | 0.800 |
Why?
|
Aortic Aneurysm, Thoracic | 5 | 2024 | 698 | 0.770 |
Why?
|
Aortic Rupture | 4 | 2020 | 317 | 0.770 |
Why?
|
Diabetic Foot | 3 | 2021 | 381 | 0.760 |
Why?
|
Saphenous Vein | 1 | 2024 | 537 | 0.740 |
Why?
|
Diabetic Angiopathies | 3 | 2021 | 822 | 0.720 |
Why?
|
Diabetes Mellitus | 6 | 2022 | 5889 | 0.700 |
Why?
|
Arteriovenous Fistula | 2 | 2022 | 314 | 0.690 |
Why?
|
Blood Vessel Prosthesis | 2 | 2023 | 956 | 0.680 |
Why?
|
Stroke | 10 | 2024 | 9962 | 0.620 |
Why?
|
Fibrinolytic Agents | 2 | 2018 | 2167 | 0.610 |
Why?
|
Leg | 2 | 2020 | 1090 | 0.590 |
Why?
|
Femoral Artery | 2 | 2024 | 835 | 0.550 |
Why?
|
Clinical Coding | 2 | 2021 | 181 | 0.520 |
Why?
|
Angioplasty, Balloon | 2 | 2020 | 597 | 0.520 |
Why?
|
Blood Coagulation | 2 | 2020 | 1157 | 0.510 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2024 | 936 | 0.500 |
Why?
|
Carotid Artery Diseases | 2 | 2018 | 883 | 0.470 |
Why?
|
Aneurysm, Infected | 1 | 2014 | 81 | 0.460 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2015 | 97 | 0.450 |
Why?
|
Canada | 10 | 2022 | 2128 | 0.450 |
Why?
|
Popliteal Artery | 1 | 2015 | 312 | 0.440 |
Why?
|
Treatment Outcome | 29 | 2024 | 65017 | 0.440 |
Why?
|
Reoperation | 2 | 2023 | 4291 | 0.440 |
Why?
|
Risk Reduction Behavior | 2 | 2016 | 1109 | 0.430 |
Why?
|
Aneurysm, False | 2 | 2015 | 257 | 0.430 |
Why?
|
Cerebral Revascularization | 1 | 2015 | 249 | 0.420 |
Why?
|
Specialization | 1 | 2017 | 778 | 0.410 |
Why?
|
Aorta, Thoracic | 3 | 2024 | 1097 | 0.400 |
Why?
|
Intracranial Hemorrhages | 1 | 2018 | 844 | 0.400 |
Why?
|
Risk Factors | 28 | 2024 | 74359 | 0.400 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2022 | 3201 | 0.390 |
Why?
|
Retrospective Studies | 29 | 2024 | 80372 | 0.380 |
Why?
|
Myocardial Infarction | 5 | 2023 | 11891 | 0.360 |
Why?
|
Time Factors | 16 | 2024 | 40165 | 0.330 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 3334 | 0.320 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2019 | 10344 | 0.310 |
Why?
|
Humans | 76 | 2024 | 760621 | 0.310 |
Why?
|
Aged | 30 | 2024 | 169152 | 0.310 |
Why?
|
Male | 44 | 2024 | 359744 | 0.310 |
Why?
|
Paclitaxel | 1 | 2015 | 1736 | 0.300 |
Why?
|
Bacteremia | 1 | 2014 | 980 | 0.290 |
Why?
|
Limb Salvage | 3 | 2024 | 465 | 0.280 |
Why?
|
Middle Aged | 30 | 2024 | 220352 | 0.270 |
Why?
|
Lower Extremity | 3 | 2024 | 1194 | 0.270 |
Why?
|
Female | 42 | 2024 | 391270 | 0.270 |
Why?
|
Staphylococcal Infections | 1 | 2014 | 1407 | 0.250 |
Why?
|
Ischemia | 3 | 2024 | 1893 | 0.250 |
Why?
|
Aged, 80 and over | 16 | 2024 | 58995 | 0.250 |
Why?
|
Embolization, Therapeutic | 1 | 2014 | 1413 | 0.240 |
Why?
|
Vascular System Injuries | 2 | 2019 | 247 | 0.230 |
Why?
|
Subclavian Artery | 1 | 2024 | 134 | 0.220 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2024 | 200 | 0.220 |
Why?
|
Home Care Services | 2 | 2021 | 654 | 0.220 |
Why?
|
Postoperative Complications | 9 | 2024 | 15697 | 0.210 |
Why?
|
Vascular Grafting | 1 | 2024 | 154 | 0.210 |
Why?
|
Risk Assessment | 12 | 2024 | 24123 | 0.190 |
Why?
|
Vena Cava Filters | 1 | 2024 | 261 | 0.190 |
Why?
|
Intermittent Claudication | 2 | 2022 | 306 | 0.190 |
Why?
|
Brachial Artery | 1 | 2023 | 366 | 0.190 |
Why?
|
Radial Artery | 1 | 2022 | 196 | 0.190 |
Why?
|
Extremities | 2 | 2016 | 867 | 0.180 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7475 | 0.180 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2017 | 1523 | 0.180 |
Why?
|
Cross-Sectional Studies | 8 | 2024 | 25942 | 0.170 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2019 | 3986 | 0.160 |
Why?
|
Coronary Artery Bypass, Off-Pump | 1 | 2019 | 65 | 0.160 |
Why?
|
Upper Extremity | 1 | 2024 | 661 | 0.160 |
Why?
|
Bioprosthesis | 1 | 2023 | 600 | 0.160 |
Why?
|
Lithotripsy | 1 | 2019 | 142 | 0.150 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6498 | 0.150 |
Why?
|
Anesthesia, Epidural | 1 | 2020 | 233 | 0.150 |
Why?
|
Comparative Effectiveness Research | 1 | 2023 | 718 | 0.150 |
Why?
|
Cattle | 1 | 2023 | 3847 | 0.140 |
Why?
|
Anesthesia, Spinal | 1 | 2020 | 280 | 0.140 |
Why?
|
Vascular Diseases | 2 | 2024 | 1182 | 0.140 |
Why?
|
Personnel Turnover | 1 | 2017 | 86 | 0.140 |
Why?
|
Health Care Surveys | 2 | 2021 | 2435 | 0.130 |
Why?
|
Health Services Needs and Demand | 2 | 2021 | 1399 | 0.130 |
Why?
|
Odds Ratio | 3 | 2017 | 9716 | 0.130 |
Why?
|
Peripheral Vascular Diseases | 1 | 2019 | 515 | 0.130 |
Why?
|
Prosthesis Design | 1 | 2023 | 2135 | 0.130 |
Why?
|
Ultrasonography, Interventional | 1 | 2024 | 1502 | 0.130 |
Why?
|
Workload | 1 | 2021 | 847 | 0.130 |
Why?
|
Preoperative Care | 1 | 2024 | 2256 | 0.120 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2017 | 435 | 0.120 |
Why?
|
Indians, North American | 1 | 2018 | 350 | 0.120 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15757 | 0.120 |
Why?
|
Patient Readmission | 2 | 2019 | 3323 | 0.120 |
Why?
|
Hypolipidemic Agents | 1 | 2019 | 626 | 0.120 |
Why?
|
Arabs | 1 | 2016 | 187 | 0.110 |
Why?
|
Propensity Score | 2 | 2019 | 1928 | 0.110 |
Why?
|
Hospital Costs | 1 | 2020 | 976 | 0.110 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12531 | 0.110 |
Why?
|
Aneurysm, Ruptured | 1 | 2018 | 460 | 0.110 |
Why?
|
Renal Insufficiency | 1 | 2019 | 820 | 0.110 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3465 | 0.110 |
Why?
|
Drug-Eluting Stents | 1 | 2020 | 757 | 0.110 |
Why?
|
Renin-Angiotensin System | 1 | 2017 | 738 | 0.110 |
Why?
|
Coronary Stenosis | 1 | 2019 | 820 | 0.110 |
Why?
|
Benchmarking | 1 | 2019 | 1044 | 0.110 |
Why?
|
Anesthesia, General | 1 | 2020 | 1166 | 0.100 |
Why?
|
Aortography | 1 | 2014 | 420 | 0.100 |
Why?
|
Wounds, Nonpenetrating | 1 | 2019 | 793 | 0.100 |
Why?
|
Patient Admission | 1 | 2020 | 1386 | 0.100 |
Why?
|
Aneurysm | 1 | 2015 | 337 | 0.100 |
Why?
|
Foot | 1 | 2015 | 573 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2019 | 895 | 0.090 |
Why?
|
Hospitalization | 3 | 2021 | 10790 | 0.090 |
Why?
|
Perioperative Care | 1 | 2018 | 1037 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1940 | 0.090 |
Why?
|
Coronary Artery Bypass | 1 | 2019 | 2272 | 0.080 |
Why?
|
Education, Medical, Undergraduate | 1 | 2019 | 1066 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2543 | 0.080 |
Why?
|
Adult | 11 | 2024 | 219994 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2363 | 0.080 |
Why?
|
Internship and Residency | 2 | 2021 | 5870 | 0.080 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2061 | 0.080 |
Why?
|
Emergency Service, Hospital | 2 | 2019 | 7818 | 0.080 |
Why?
|
United States | 4 | 2024 | 72461 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2608 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9280 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2581 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2023 | 3517 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4283 | 0.070 |
Why?
|
Mortality | 1 | 2018 | 2916 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3696 | 0.070 |
Why?
|
International Classification of Diseases | 2 | 2023 | 894 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1830 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2420 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3164 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13314 | 0.070 |
Why?
|
Patient Discharge | 1 | 2019 | 3476 | 0.070 |
Why?
|
Health Care Costs | 1 | 2019 | 3258 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 3150 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2283 | 0.060 |
Why?
|
Hemorrhage | 1 | 2018 | 3600 | 0.060 |
Why?
|
Students, Medical | 1 | 2019 | 1927 | 0.060 |
Why?
|
Specialties, Surgical | 2 | 2021 | 388 | 0.060 |
Why?
|
General Surgery | 1 | 2017 | 1678 | 0.060 |
Why?
|
Registries | 1 | 2021 | 8469 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2020 | 3763 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3865 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2016 | 2064 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12159 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15289 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39261 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3388 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2016 | 3127 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2020 | 22053 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8056 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6381 | 0.050 |
Why?
|
Aorta, Abdominal | 1 | 2024 | 625 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 20509 | 0.050 |
Why?
|
Blood Pressure | 1 | 2016 | 8525 | 0.040 |
Why?
|
Prospective Studies | 2 | 2022 | 54303 | 0.040 |
Why?
|
Quality of Life | 1 | 2022 | 13308 | 0.040 |
Why?
|
Ecology | 1 | 2020 | 103 | 0.040 |
Why?
|
Anesthetics, Combined | 1 | 2020 | 43 | 0.040 |
Why?
|
Interviews as Topic | 2 | 2019 | 2659 | 0.040 |
Why?
|
Cohort Studies | 1 | 2023 | 41335 | 0.040 |
Why?
|
Educational Status | 2 | 2019 | 2515 | 0.040 |
Why?
|
Antithrombin III | 1 | 2020 | 129 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2024 | 594 | 0.040 |
Why?
|
Nursing Services | 1 | 2019 | 6 | 0.040 |
Why?
|
Prothrombin | 1 | 2020 | 191 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6659 | 0.040 |
Why?
|
Angiography | 1 | 2024 | 1605 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8594 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 12293 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12914 | 0.040 |
Why?
|
Aortic Diseases | 1 | 2024 | 736 | 0.040 |
Why?
|
Blood Coagulation Factors | 1 | 2020 | 365 | 0.040 |
Why?
|
New York | 1 | 2020 | 875 | 0.040 |
Why?
|
Retreatment | 1 | 2019 | 600 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2020 | 623 | 0.040 |
Why?
|
Societies, Medical | 2 | 2019 | 3905 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 1098 | 0.030 |
Why?
|
Saudi Arabia | 1 | 2016 | 209 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1765 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2019 | 1033 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6479 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12808 | 0.030 |
Why?
|
Ligation | 1 | 2015 | 448 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2024 | 2001 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1677 | 0.030 |
Why?
|
Universities | 1 | 2019 | 992 | 0.030 |
Why?
|
Sex Factors | 2 | 2017 | 10547 | 0.030 |
Why?
|
Educational Measurement | 1 | 2019 | 1248 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13502 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1881 | 0.020 |
Why?
|
Animals | 1 | 2023 | 167963 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2696 | 0.020 |
Why?
|
Career Choice | 1 | 2017 | 754 | 0.020 |
Why?
|
Perception | 1 | 2016 | 1195 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6544 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5125 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29658 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8555 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10551 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4775 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3928 | 0.020 |
Why?
|
Curriculum | 1 | 2019 | 3718 | 0.020 |
Why?
|
Life Style | 1 | 2017 | 3896 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9287 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20080 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3836 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 13981 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15687 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18416 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 58741 | 0.010 |
Why?
|
Adolescent | 1 | 2015 | 87810 | 0.000 |
Why?
|